Tag: Drug Marking

The cost of drug labeling implementation is considered as reasonable

According to market participants, the costs of drug manufacturers on mandatory implementation of labeling by 2020 will not increase the cost of drugs.

Takeda produced three pilot batches of Actovegin as part of drug labeling project

Three pilot batches of Actovegin in the total amount of more than 40 thousand packages were produced under the drug labeling project involving the application of special 2D code.

IDF approved the first loan under Drug Labeling program

The Expert Council of the Industrial Development Fund (IDF) has approved the first loan under the Drug Labeling program. The loan was provided to Polysan Scientific & Technological Pharmaceutical Company from St. Petersburg.

Russian government approved operation model for product labeling system

Prime Minister of the Russian Federation signed the Order No. 791-r of April 28, 2018, which approved the operation model for the system of labeling products by means of identification in the Russian Federation.

Loans to purchase drug labeling equipment are available at 1% per annum

Industrial Development Fund (IDF) launched a new preferential lending program for the purchase of drug labeling equipment. The key feature of the program is that the company is not required to co-finance the project.

Antares Vision presented its new software for pharmaceutical serialization

Antares Vision has introduced ATSFour, an enterprise-level serialization software aimed at fighting counterfeiting in the pharmaceutical industry.

Kazakhstan plans to introduce drug labeling by 2023

Kazakhstan plans to apply a 2D barcode on secondary packaging of drugs to track the movement of products, starting from their importation to Kazakhstan and up to the sale in pharmacies or delivering in medical institutions.

Desitin puts Track & Trace solution into effect at its Hamburg plant

Desitin required a lean, powerful and easy to implement track-and-trace solution to comply with the anti-counterfeiting requirements of its various international target markets.

Serialisation software provider SEA Vision expands its operations in Russia

SEA Vision, which has over 20 customers in Russia and has installed over 800 full track and trace systems globally, is expanding its presence in Russia to offer local sales and technical support for its clients.

Russia establishes its National Quality Infrastructure Council

On March 14, Denis Manturov, the Russian Minister of Industry and Trade, chaired a meeting of the State Commission on Counteraction to Illegal Circulation of Industrial Products.

Project of EAEU unified goods traceability system was presented to the public

The unified goods traceability system in the EAEU will provide consumers with access to reliable information about products, allow businesses to reduce their transaction costs, let member states to monitor the payment of taxes.

Kurgan-based Sintez will invest 200 million rubles in labeling equipment

sintez kurgan
By 2020, JSC Joint-Stock Kurgan Company of Medicinal Products and Devices Sintez will invest more than 200 million rubles in the drug labeling equipment.

8 million packages of medicines were labeled in Russia in 2017

In 2017, more than 8 million packages of medicines were labeled in Russia to protect consumers from using substandard products. This was announced by Mikhail Mishustin, the head of the Russian Federal Tax Service.

Experts say that introduction of labeling will not result in price increase

The pharmaceutical industry expects a positive effect from the introduction of drug labeling and tracking system. This is the opinion expressed by the industry experts.

Rostec starts digital labeling of medicinal products manufactured at its plants

As part of the drug labeling project, NPO Microgen of Nacimbio holding company, a part of Rostec Corporation, has completed the initial pilot stage

Mandatory labeling for 7 nosologies may be introduced in 2018

drug marking
In 2020, the labeling of medicinal products will become mandatory for all manufacturers. But, for some drugs, including the expensive medicines, it may happen as early as in 2018